IQVIA Holdings Inc.

IQV · NYSE · USD

PoliticiansInstitutionalInsiders

Current holders

Politician	Disclosed
Donald Trump R · EXECUTIVE	net −$413K – −$18K 11 disclosures · 4 bought / 7 sold · last Aug 26, 2026
Kurt Schrader D · HOUSE · OR	$252K – $530K $268K – $567K today 4 filings · last Feb 28, 2022
Markwayne Mullin R · SENATE · OK	$45K – $150K $57K – $189K today 3 filings · last Dec 29, 2025
Kevin Hern R · HOUSE · OK	−$79K – $247K −$134K – $269K today 8 filings · last Sep 14, 2026
Thad Cochran R · HOUSE · MS	$15K – $50K $42K – $139K today 1 filing · last Feb 20, 2018
Robert Bresnahan R · HOUSE · PA	−$15K – $48K −$23K – $93K today 3 filings · last May 15, 2025
Ro Khanna D · HOUSE · CA	−$386K – $364K −$667K – $613K today 51 filings · last Jun 30, 2026
Susie Lee D · HOUSE · NV	−$72K – $40K −$129K – $75K today 8 filings · last May 9, 2023

Recent transactions

Trades from Aug 2, 2024 – Aug 26, 2026

Politician	Type	Filed after	Amount
Donald Trump R · EXECUTIVE	Sell	43 days Aug 26, 2026 → Oct 8, 2026	≥$15K
Kevin Hern R · HOUSE · OK-1	Sell	11 days Sep 14, 2026 → Sep 25, 2026	≥$15K
Kevin Hern R · HOUSE · OK-1	Sell	17 days Sep 8, 2026 → Sep 25, 2026	≥$1K
Kevin Hern R · HOUSE · OK-1	Sell	22 days Sep 3, 2026 → Sep 25, 2026	≥$1K
Donald Trump R · EXECUTIVE	Sell	60 days Jun 23, 2026 → Aug 22, 2026	≥$1K
Ro Khanna D · HOUSE · CA-17	Sell	6 days Jun 30, 2026 → Jul 6, 2026	≥$1K
Ro Khanna D · HOUSE · CA-17	Sell	34 days Jun 2, 2026 → Jul 6, 2026	≥$1K
Donald Trump R · EXECUTIVE	Sell	40 days May 22, 2026 → Jul 1, 2026	≥$15K
Donald Trump R · EXECUTIVE	Buy	41 days May 21, 2026 → Jul 1, 2026	≥$1K
Ro Khanna D · HOUSE · CA-17	Sell	13 days May 27, 2026 → Jun 9, 2026	≥$1K

Congressional trading data provided by QuiverQuant

Institutional

Investors holding

1,123

13F shares

158.3M

Total invested

$30.5B

Ownership

94.0%

New positions

135

Closed positions

116

Increased positions

533

Reduced positions

435

Put/Call ratio

1.26

Holder	Reported	Shares	Value	Δ Qtr
BLACKROCK, INC.	8/7/2026	14.5M	$2.8B	−3.18%
HARRIS ASSOCIATES L P	8/14/2026	12.2M	$2.4B	+0.00%
VANGUARD CAPITAL MANAGEMENT LLC	8/13/2026	10.9M	$2.1B	−1.11%
STATE STREET CORP	9/22/2026	7.5M	$1.5B	+0.42%
VANGUARD PORTFOLIO MANAGEMENT LLC	8/13/2026	7.5M	$1.4B	−0.98%
JPMORGAN CHASE & CO	8/12/2026	6.1M	$1.2B	+13.54%
ARTISAN PARTNERS LIMITED PARTNERSHIP	8/13/2026	4.7M	$916.5M	−6.24%
BOSTON PARTNERS	8/4/2026	4.5M	$865.5M	+5.36%
GEODE CAPITAL MANAGEMENT, LLC	8/12/2026	4.5M	$857.2M	−0.20%
INVESCO LTD.	8/14/2026	3.3M	$632.8M	+0.41%
MORGAN STANLEY	8/13/2026	2.7M	$523.1M	+3.73%
NORGES BANK	8/12/2026	2.3M	$437.6M	—
FRANKLIN RESOURCES INC	8/13/2026	2.1M	$406.8M	+317.50%
GOLDMAN SACHS GROUP INC	8/14/2026	1.9M	$376.7M	+65.62%
DIMENSIONAL FUND ADVISORS LP	8/11/2026	1.7M	$335.3M	+4.69%
NORTHERN TRUST CORP	8/13/2026	1.7M	$330.2M	−1.20%
UBS ASSET MANAGEMENT AMERICAS INC	8/13/2026	1.6M	$315.8M	+9.00%
AQR CAPITAL MANAGEMENT LLC	8/14/2026	1.5M	$297.0M	+23.86%
LONGVIEW PARTNERS (GUERNSEY) LTD	8/13/2026	1.5M	$290.0M	−20.91%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.	8/14/2026	1.5M	$286.7M	—
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	8/14/2026	1.5M	$286.7M	+5.09%
ALLIANCEBERNSTEIN L.P.	8/14/2026	1.6M	$280.2M	−42.93%
LYRICAL ASSET MANAGEMENT LP	8/12/2026	1.3M	$243.4M	—
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	8/13/2026	1.3M	$241.5M	+25.99%
CANADA PENSION PLAN INVESTMENT BOARD	8/14/2026	1.2M	$240.9M	−37.63%

Insider transactions

Insider	Type	Transacted	Price	Date
Berkshire James G.	S-SALE	2.7K	$261.33	Sep 2
Berkshire James G.	M-EXEMPT	5.4K	$131.82	Sep 2
Berkshire James G.	M-EXEMPT	5.4K	$131.82	Sep 2
Berkshire James G.	D-RETURN	2.7K	$261.54	Sep 2
Staub W Richard	S-SALE	5.5K	$232.68	Aug 3
Patel Bhavik	S-SALE	1.9K	$235.27	Jul 31
Sherbet Eric	S-SALE	5K	$249.16	Jul 29
Cherofsky Keriann	S-SALE	558	$245.21	Jul 29
Bousbib Ari	S-SALE	53.2K	$244.78	Jul 29
Bousbib Ari	S-SALE	44K	$246.08	Jul 29

Analyst consensus

Buy45 analysts

Bearish · 1 · Hold · 7 · Bullish · 37

Earnings history

	EPS	Estimate
Q3 2024	$2.84	$2.82	Beat
Q4 2024	$3.12	$3.11	Beat
Q1 2025	$2.70	$2.63	Beat
Q2 2025	$2.81	$2.77	Beat
Q3 2025	$3.00	$2.98	Beat
Q4 2025	$3.42	$3.40	Beat
Q1 2026	$2.90	$2.82	Beat
Q2 2026	$3.15	$3.03	Beat

Peers

Company overview

IPO dateMay 9, 2013

CEOAri Bousbib

Employees94,000

SectorHealthcare

IndustryMedical - Diagnostics & Research

CountryUS

ExchangeNew York Stock Exchange

Websitewww.iqvia.com

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.